Cardiff Oncology (CRDF) Cash & Equivalents (2011 - 2026)
Cardiff Oncology (CRDF) reported Cash & Equivalents of $9.2 million for Q2 2026, down 14.7% from $10.78 million a year earlier.
Powered by 
Analysis
Cardiff Oncology (CRDF) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Cardiff Oncology posted Cash & Equivalents of $17.47 million, down 66.1% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -33.2% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $51.47 million in FY2024 (+137.7%), $21.66 million in FY2023 (+32.5%), $16.35 million in FY2022 (+36.9%) and $11.94 million in FY2021 (-90.9%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q3 2019.
- Year over year, Cash & Equivalents gained in two of the last seven quarters, with an average decline of 1.2%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2024 (growth of 137.7%); the low point was Q4 2021 (a decline of 90.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Cardiff Oncology | 62.34 Mn | 27.84 Mn | - | 9.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.20 Mn |
| Dec 31, 2025 | 17.47 Mn |
| Sep 30, 2025 | 10.14 Mn |
| Jun 30, 2025 | 10.78 Mn |
| Mar 31, 2025 | 24.10 Mn |
| Dec 31, 2024 | 51.47 Mn |
| Sep 30, 2024 | 13.04 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Mar 31, 2024 | 18.66 Mn |
| Dec 31, 2023 | 21.66 Mn |
| Sep 30, 2023 | 15.23 Mn |
| Jun 30, 2023 | 19.37 Mn |
| Mar 31, 2023 | 15.02 Mn |
| Dec 31, 2022 | 16.35 Mn |
| Sep 30, 2022 | 18.72 Mn |
| Jun 30, 2022 | 20.97 Mn |
| Mar 31, 2022 | 20.05 Mn |
| Dec 31, 2021 | 11.94 Mn |
| Sep 30, 2021 | 13.17 Mn |
| Jun 30, 2021 | 10.58 Mn |
API Access
Cardiff Oncology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();